This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mady, C. Articles by Pileggi, F. Search for Related Content PubMed PubMed Citation Articles by Mady, C. Articles by Pileggi, F.

Circulation, Vol 90, 3098-3102, Copyright © 1994 by American Heart Association

ARTICLES

Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy

C Mady, RH Cardoso, AC Barretto, PL da Luz, G Bellotti and F Pileggi
Heart Institute, University of Sao Paulo Medical School, Brazil.

BACKGROUND: The fundamental determinant of the natural history of Chagas' disease is cardiac involvement. METHODS AND RESULTS: We studied 104 male patients with congestive heart failure due to Chagas' disease to estimate the survival distribution function and to evaluate age, functional class (FC), maximal oxygen consumption (VO2max), and ejection fraction (EF) as predictors of survival. Statistical evaluation was performed through univariate (Student's t test and chi 2 test) and multivariate analyses (Cox's regression model). Overall survival was 66% at 1 year, 56% at 3 years, and 48% at 5 years. Ages were not statistically different (P = .9811) between survivor (40.3 +/- 8.7) and nonsurvivor (40.3 +/- 9.4) groups. The ejection fraction(s) were statistically different (P = .0001) between survival (43.6 +/- 9.9) and nonsurvival (30.6 +/- 8.1) groups, as was VO2max (P = .0001) (21.0 +/- 4.7 and 15.0 +/- 4.9, respectively). Most of the surviving patients were in FC II and most of the nonsurvivors were in FC IV (P = .0001). VO2max (P = .0001) and EF (P = .0008) are highly associated with survival time in the multivariate analysis, but FC (P = .0578) is less important. Age (P = .9811) did not influence survival. CONCLUSIONS: We conclude that 50% of the patients with heart failure due to Chagas' disease die in 47 months and that VO2max and EF are important indices of survival in this group.

This article has been cited by other articles:

				C. Bern, S. P. Montgomery, B. L. Herwaldt, A. Rassi Jr, J. A. Marin-Neto, R. O. Dantas, J. H. Maguire, H. Acquatella, C. Morillo, L. V. Kirchhoff, et al. Evaluation and Treatment of Chagas Disease in the United States: A Systematic Review JAMA, November 14, 2007; 298(18): 2171 - 2181. [Abstract] [Full Text] [PDF]

				A. Rassi Jr, A. Rassi, and S. G. Rassi Predictors of Mortality in Chronic Chagas Disease: A Systematic Review of Observational Studies Circulation, March 6, 2007; 115(9): 1101 - 1108. [Abstract] [Full Text] [PDF]

				H. Acquatella Echocardiography in Chagas Heart Disease Circulation, March 6, 2007; 115(9): 1124 - 1131. [Abstract] [Full Text] [PDF]

				A. Rassi Jr., A. Rassi, W. C. Little, S. S. Xavier, S. G. Rassi, A. G. Rassi, G. G. Rassi, A. Hasslocher-Moreno, A. S. Sousa, and M. I. Scanavacca Development and Validation of a Risk Score for Predicting Death in Chagas' Heart Disease N. Engl. J. Med., August 24, 2006; 355(8): 799 - 808. [Abstract] [Full Text] [PDF]

				C. E. Rochitte, P. F. Oliveira, J. M. Andrade, B. M. Ianni, J. R. Parga, L. F. Avila, R. Kalil-Filho, C. Mady, J. C. Meneghetti, J. A.C. Lima, et al. Myocardial Delayed Enhancement by Magnetic Resonance Imaging in Patients With Chagas' Disease: A Marker of Disease Severity J. Am. Coll. Cardiol., October 18, 2005; 46(8): 1553 - 1558. [Abstract] [Full Text] [PDF]

				M. Montes de Oca, S. H. Torres, J. G. Loyo, F. Vazquez, N. Hernandez, B. Anchustegui, and J. J. Puigbo Exercise Performance and Skeletal Muscles in Patients With Advanced Chagas Disease Chest, April 1, 2004; 125(4): 1306 - 1314. [Abstract] [Full Text] [PDF]

				G. Salles, S. Xavier, A. Sousa, A. Hasslocher-Moreno, and C. Cardoso Prognostic Value of QT Interval Parameters for Mortality Risk Stratification in Chagas' Disease: Results of a Long-Term Follow-Up Study Circulation, July 22, 2003; 108(3): 305 - 312. [Abstract] [Full Text] [PDF]

				F J Carod-Artal, A P Vargas, M Melo, and T A Horan American trypanosomiasis (Chagas' disease): an unrecognised cause of stroke J. Neurol. Neurosurg. Psychiatry, April 1, 2003; 74(4): 516 - 518. [Abstract] [Full Text] [PDF]

				M. Lima-Costa, S. Barreto, H. Guerra, and J. C Villar Chagas' disease among older adults: branches or mainstream of the present burden of Trypanosoma cruzi infection? Int. J. Epidemiol., June 1, 2002; 31(3): 688 - 689. [Full Text] [PDF]